Loading...

Andlauer Healthcare Group Inc.

AND.TOTSX
Industrials
Integrated Freight & Logistics
CA$53.19
CA$0.19(0.36%)

Andlauer Healthcare Group Inc. (AND.TO) Financial Performance & Income Statement Overview

Review Andlauer Healthcare Group Inc. (AND.TO) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
0.39%
0.39%
Operating Income Growth
-2.18%
2.18%
Net Income Growth
-2.53%
2.53%
Operating Cash Flow Growth
19.14%
19.14%
Operating Margin
14.39%
14.39%
Gross Margin
22.87%
22.87%
Net Profit Margin
10.64%
10.64%
ROE
16.58%
16.58%
ROIC
16.34%
16.34%

Andlauer Healthcare Group Inc. (AND.TO) Income Statement & Financial Overview

Review Andlauer Healthcare Group Inc. AND.TO income statement with detailed quarterly and annual figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$166.09M$168.29M$159.60M$161.45M
Cost of Revenue$129.34M$128.79M$122.37M$125.03M
Gross Profit$36.75M$39.50M$37.23M$36.42M
Gross Profit Ratio$0.22$0.23$0.23$0.23
R&D Expenses$0.00$0.00$0.00$0.00
SG&A Expenses$15.18M$12.76M$13.42M$14.24M
Operating Expenses$15.18M$12.76M$13.42M$14.24M
Total Costs & Expenses$144.52M$141.55M$135.79M$139.27M
Interest Income$323000.00$260000.00$494000.00$703000.00
Interest Expense$1.96M$2.11M$2.19M$1.71M
Depreciation & Amortization$17.94M$17.62M$17.37M$17.60M
EBITDA$45.34M$43.83M$41.81M$39.78M
EBITDA Ratio$0.27$0.26$0.26$0.25
Operating Income$21.57M$26.74M$23.81M$22.18M
Operating Income Ratio$0.13$0.16$0.15$0.14
Other Income/Expenses (Net)$3.88M-$2.64M-$1.55M-$702000.00
Income Before Tax$25.45M$24.10M$22.26M$21.47M
Income Before Tax Ratio$0.15$0.14$0.14$0.13
Income Tax Expense$5.22M$6.57M$5.97M$5.74M
Net Income$20.23M$17.53M$16.29M$15.73M
Net Income Ratio$0.12$0.10$0.10$0.10
EPS$0.50$0.44$0.41$0.38
Diluted EPS$0.49$0.43$0.41$0.38
Weighted Avg Shares Outstanding$40.28M$39.25M$39.39M$41.11M
Weighted Avg Shares Outstanding (Diluted)$40.88M$39.84M$39.95M$41.76M

Over the last four quarters, Andlauer Healthcare Group Inc. achieved steady financial progress, growing revenue from $161.45M in Q2 2024 to $166.09M in Q1 2025. Gross profit stayed firm with margins at 22% in Q1 2025 versus 23% in Q2 2024. Operating income totaled $21.57M in Q1 2025, maintaining a 13% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $45.34M. Net income rose to $20.23M, with EPS at $0.50. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;